Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$19.91 - $68.26 $477,840 - $1.64 Million
24,000 Added 133.33%
42,000 $1.38 Million
Q3 2020

Nov 12, 2020

BUY
$68.34 - $85.84 $1.23 Million - $1.55 Million
18,000 New
18,000 $1.28 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.45B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.